|
|
|
|
Document Preview Agreement and Plan of Merger |
||||
|
|
||||
|
Click "Add to Cart" button to purchase document. |
||||
|
|
||||
|
Title: |
Agreement and Plan of Merger |
|||
|
Entities: |
AngioDynamics, Inc.; RITA Medical Systems, Inc.; Heller Ehrman White & McAuliffe; Skadden, Arps, Slate, Meagher & Flom LLP |
|||
|
Date: |
2006 |
|||
|
Size: |
Preview shows 15KB of 353KB total |
|||
|
Price: |
$99 |
|||
|
ID: |
#2646114 |
|||
|
|
||||
|
||||
|
|
||||
|
Start of Preview |
||||
AGREEMENT AND PLAN OF MERGER
BY AND AMONG
ANGIODYNAMICS, INC.
ROYAL I, LLC
AND
RITA MEDICAL SYSTEMS, INC.
NOVEMBER 27, 2006
===============================================================================
{PAGE}
{TABLE}
{CAPTION}
TABLE OF CONTENTS
Page
{S} {C} {C}
SECTION 1. THE MERGER......................................................................................2
1.1 MERGER OF THE COMPANY INTO MERGER SUB...........................................................2
1.2 EFFECT OF THE MERGER............................................................................2
1.3 CLOSING; EFFECTIVE TIME.........................................................................2
1.4 LIMITED LIABILITY COMPANY OPERATING AGREEMENT...................................................2
1.5 EFFECT OF THE MERGER............................................................................2
1.6 CLOSING OF THE COMPANY'S TRANSFER BOOKS.........................................................3
1.7 EXCHANGE OF CERTIFICATES........................................................................4
1.8 FURTHER ACTION..................................................................................5
1.9 APPRAISAL RIGHTS................................................................................5
1.10 TAX CONSEQUENCES................................................................................5
SECTION 2. REPRESENTATIONS AND WARRANTIES OF THE COMPANY...................................................6
2.1 DUE ORGANIZATION; SUBSIDIARIES..................................................................6
2.2 AUTHORITY; BINDING NATURE OF AGREEMENT..........................................................6
2.3 CAPITALIZATION, ETC.............................................................................7
2.4 NON-CONTRAVENTION; CONSENTS.....................................................................9
2.5 SEC FILINGS; FINANCIAL STATEMENTS...............................................................9
2.6 ABSENCE OF CHANGES.............................................................................11
2.7 PROPRIETARY ASSETS.............................................................................12
2.8 CONTRACTS......................................................................................14
2.9 LIABILITIES....................................................................................16
2.10 COMPLIANCE WITH LEGAL REQUIREMENTS; FDA MATTERS................................................16
2.11 GOVERNMENTAL AUTHORIZATIONS....................................................................19
2.12 TAX MATTERS....................................................................................19
2.13 EMPLOYEE AND LABOR MATTERS; BENEFIT PLANS......................................................20
2.14 ENVIRONMENTAL MATTERS..........................................................................24
2.15 LEGAL PROCEEDINGS; ORDERS......................................................................25
2.16 VOTE REQUIRED..................................................................................25
2.17 FOREIGN CORRUPT PRACTICES ACT..................................................................25
2.18 REAL PROPERTY..................................................................................26
2.19 INSURANCE POLICIES.............................................................................26
2.20 INFORMATION TO BE SUPPLIED.....................................................................26
2.21 TAKEOVER STATUTES; COMPANY RIGHTS PLAN.........................................................27
2.22 FINANCIAL ADVISOR..............................................................................27
2.23 OPINION OF FINANCIAL ADVISOR...................................................................27
2.24 AFFILIATE TRANSACTIONS.........................................................................27
SECTION 3. REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB........................................28
3.1 DUE ORGANIZATION; SUBSIDIARIES.................................................................28
3.2 AUTHORITY; BINDING NATURE OF AGREEMENT.........................................................28
3.3 CAPITALIZATION, ETC............................................................................29
3.4 NON-CONTRAVENTION; CONSENTS....................................................................30
3.5 SEC FILINGS; FINANCIAL STATEMENTS..............................................................31
{/TABLE}
i
{PAGE}
{TABLE}
{CAPTION}
{S} {C} {C}
3.6 ABSENCE OF CHANGES.............................................................................32
3.7 PROPRIETARY ASSETS.............................................................................33
3.8 CONTRACTS......................................................................................35
3.9 LIABILITIES....................................................................................37
3.10 COMPLIANCE WITH LEGAL REQUIREMENTS; FDA MATTERS................................................37
3.11 GOVERNMENTAL AUTHORIZATIONS....................................................................40
3.12 TAX MATTERS....................................................................................41
3.13 EMPLOYEE AND LABOR MATTERS; BENEFIT PLANS......................................................42
3.14 ENVIRONMENTAL MATTERS..........................................................................44
3.15 LEGAL PROCEEDINGS; ORDERS......................................................................45
3.16 VOTE REQUIRED..................................................................................45
3.17 FOREIGN CORRUPT PRACTICES ACT..................................................................45
3.18 REAL PROPERTY..................................................................................46
3.19 INSURANCE POLICIES.............................................................................46
3.20 INFORMATION TO BE SUPPLIED.....................................................................46
3.21 TAKEOVER STATUTES; RIGHTS PLAN.................................................................47
3.22 FINANCIAL ADVISOR..............................................................................47
3.23 OPINION OF FINANCIAL ADVISOR...................................................................47
3.24 AFFILIATE TRANSACTIONS.........................................................................47
SECTION 4. CERTAIN COVENANTS OF THE COMPANY AND PARENT....................................................47
4.1 ACCESS AND INVESTIGATION.......................................................................47
4.2 OPERATION OF BUSINESS..........................................................................48
4.3 NO SOLICITATION BY THE COMPANY.................................................................52
SECTION 5. ADDITIONAL COVENANTS OF THE PARTIES............................................................54
5.1 REGISTRATION STATEMENT AND PROXY STATEMENT FOR STOCKHOLDER APPROVAL............................54
5.2 COMPANY SHAREHOLDERS' MEETING AND PARENT STOCKHOLDERS' MEETING.................................55
5.3 REGULATORY APPROVALS...........................................................................56
5.4 COMPANY STOCK OPTIONS AND WARRANTS.............................................................57
5.5 EMPLOYEE BENEFITS..............................................................................58
5.6 INDEMNIFICATION OF OFFICERS AND DIRECTORS......................................................59
5.7 ADDITIONAL AGREEMENTS..........................................................................60
5.8 PUBLIC DISCLOSURE..............................................................................61
5.9 TAX MATTERS....................................................................................61
5.10 RESIGNATION OF DIRECTORS.......................................................................61
5.11 NASDAQ LISTING OF ADDITIONAL SHARES............................................................61
5.12 TAKEOVER LAWS; RIGHTS PLANS....................................................................61
5.13 FORM S-8; SECTION 16...........................................................................62
5.14 LITIGATION.....................................................................................62
5.15 ADVICE OF CHANGES..............................................................................62
5.16 DIRECTORS OF PARENT............................................................................63
5.17 RULE 145 AFFILIATES............................................................................63
SECTION 6. CONDITIONS TO THE MERGER.......................................................................63
6.1 CONDITIONS TO EACH PARTY'S OBLIGATION..........................................................63
{/TABLE}
ii
{PAGE}
{TABLE}
{CAPTION}
{S} {C} {C}
6.2 ADDITIONAL CONDITIONS TO PARENT'S AND MERGER SUB'S OBLIGATIONS.................................64
6.3 ADDITIONAL CONDITIONS TO THE COMPANY'S OBLIGATIONS.............................................65
SECTION 7. TERMINATION....................................................................................66
7.1 TERMINATION....................................................................................66
7.2 EFFECT OF TERMINATION..........................................................................67
7.3 EXPENSES; TERMINATION FEES.....................................................................67
SECTION 8. MISCELLANEOUS PROVISIONS.......................................................................68
8.1 AMENDMENT......................................................................................68
8.2 WAIVER.........................................................................................68
8.3 NO SURVIVAL OF REPRESENTATIONS AND WARRANTIES..................................................68
8.4 ENTIRE AGREEMENT; COUNTERPARTS.................................................................68
8.5 APPLICABLE LAW; JURISDICTION...................................................................68
8.6 ATTORNEYS' FEES................................................................................69
8.7 ASSIGNABILITY; THIRD PARTY BENEFICIARIES.......................................................69
8.8 NOTICES........................................................................................70
8.9 SEVERABILITY...................................................................................70
8.10 SPECIFIC PERFORMANCE...........................................................................71
8.11 CONSTRUCTION...................................................................................71
{/TABLE}
iii
{PAGE}
AGREEMENT AND PLAN OF MERGER
THIS AGREEMENT AND PLAN OF MERGER (this "Agreement") is made
and entered into on November 27, 2006, by and among ANGIODYNAMICS, INC., a
Delaware corporation ("Parent"), ROYAL I, LLC, a Delaware limited liability
company and a direct, wholly-owned subsidiary of Parent ("Merger Sub"), and
RITA MEDICAL SYSTEMS, INC., a Delaware corporation (the "Company"). Certain
capitalized terms used in this Agreement are defined in Exhibit A.
|
End of Preview |
Home Intelligence Services Subscriptions News About Us